A molecular signature of dormancy in CD34(+)CD38(-) acute myeloid leukaemia cells.

A molecular signature of dormancy in CD34(+)CD38(-) acute myeloid leukaemia cells.
复制标题

DOI:
10.18632/oncotarget.22808
复制
发表时间:
2017-12-19
期刊:
影响因子:
--
通讯作者:
Pallis M
Pallis M
中科院分区:
其他
文献类型:
--
作者:
Al-Asadi MG;Brindle G;Castellanos M;May ST;Mills KI;Russell NH;Seedhouse CH;Pallis M

文献摘要

参考文献

被引文献

相似文献

Dormant leukaemia initiating cells in the bone marrow niche are a crucial therapeutic target for total eradication of acute myeloid leukaemia. To study this cellular subset we created and validated an in vitro model employing the cell line TF-1a, treated with Transforming Growth Factor β1 (TGFβ1) and a mammalian target of rapamycin inhibitor. The treated cells showed decreases in total RNA, Ki-67 and CD71, increased aldehyde dehydrogenase activity, forkhead box 03A (FOX03A) nuclear translocation and growth inhibition, with no evidence of apoptosis or differentiation. Using human genome gene expression profiling we identified a signature enriched for genes involved in adhesion, stemness/inhibition of differentiation and tumour suppression as well as canonical cell cycle regulation. The most upregulated gene was the osteopontin-coding gene SPP1. Dormant cells also demonstrated significantly upregulated beta 3 integrin (ITGB3) and CD44, as well as increased adhesion to their ligands vitronectin and hyaluronic acid as well as to bone marrow stromal cells. Immunocytochemistry of bone marrow biopsies of AML patients confirmed the positive expression of osteopontin in blasts near the para-trabecular bone marrow, whereas osteopontin was rarely detected in mononuclear cell isolates. Unsupervised hierarchical clustering of the dormancy gene signature in primary acute myeloid leukaemia samples from the Cancer Genome Atlas identified a cluster enriched for dormancy genes associated with poor overall survival.
DOI: 10.1371/journal.pbio.0040083
发表时间: 2006-03
期刊: PLoS biology
影响因子: 9.8
作者:
Coller HA;Sang L;Roberts JM
通讯作者: Roberts JM
DOI: 10.1084/jem.20081297
发表时间: 2008-09-29
期刊: The Journal of experimental medicine
影响因子: --
作者:
Chen C;Liu Y;Liu R;Ikenoue T;Guan KL;Liu Y;Zheng P
通讯作者: Zheng P
DOI: 10.3892/mco.2017.1302
发表时间: 2017-08-01
影响因子: 1.2
作者:
Chen, Yong-Bing;Ren, Si-Mei;Du, Zhongli
通讯作者: Du, Zhongli
DOI: 10.1038/nature12612
发表时间: 2013-10-31
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --
DOI: 10.1182/blood-2012-12-475483
发表时间: 2013-06-13
期刊: BLOOD
影响因子: 20.3
作者:
Boyerinas, Benjamin;Zafrir, Maya;Sipkins, Dorothy A.
通讯作者: Sipkins, Dorothy A.